Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
Despite the growing number of new drugs approved for the treatment of inflammatory bowel disease (IBD), the long-term clinical use of thiopurine therapy and the well-known properties of conventional drugs including azathioprine have made their place in IBD therapy extremely valuable. Despite the fac...
Saved in:
Main Authors: | Slavica Lazarević (Author), Maja Đanic (Author), Hani Al-Salami (Author), Armin Mooranian (Author), Momir Mikov (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
by: Momir Mikov, et al.
Published: (2023) -
Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions
by: Maja Đanić, et al.
Published: (2023) -
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites
by: Maja Đanić, et al.
Published: (2024) -
A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds
by: Armin Mooranian, et al.
Published: (2020) -
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Maja Ðanić, et al.
Published: (2018)